Managing Cutaneous Lymphoma during the COVID-19 Pandemic

April 12, 2020

United States Cutaneous Lymphoma Consortium (USCLC)

Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic

April 2020

National Comprehensive Cancer Network (NCCN)
Short-term guidelines for managing cutaneous lymphoma during the COVID-19 pandemic

News for Patients

April 2020

During this time of crisis, we applaud the many pharmaceutical companies helping. An example is Helsinn, who in the U.S. is waiving co-pays for cutaneous lymphoma patients for the durations of pandemic.